Inozyme Pharma, Inc.
INZY · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$28 | -$27 | -$25 | -$27 |
| Dep. & Amort. | -$1 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2 | $2 | $2 | $2 |
| Change in WC | $0 | $6 | -$2 | $2 |
| Other Non-Cash | $0 | -$0 | -$0 | $0 |
| Operating Cash Flow | -$29 | -$19 | -$25 | -$24 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$18 | -$29 | -$28 | -$49 |
| Inv. Sales/Matur. | $52 | $44 | $51 | $67 |
| Other Inv. Act. | $0 | $0 | $0 | $18 |
| Investing Cash Flow | $34 | $15 | $23 | $18 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $10 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $0 | $11 | $0 |
| Forex Effect | $0 | -$0 | -$0 | -$0 |
| Net Chg. in Cash | $5 | -$3 | $10 | -$5 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $21 | $25 | $15 | $21 |
| End Cash | $26 | $21 | $25 | $15 |
| Free Cash Flow | -$29 | -$19 | -$25 | -$24 |